Search

M2 PHARMA-November 25, 2022-Co-authored Paper on Development and Validation of a Sensitive Liquid Chromatography with Time-Of-Flight Mass Spectrometry Assay for In Vivo Pharmacokinetic Study of Epigallocatechin-gallate octaacetate Published in Frontiers [...]

M2 PHARMA-April 5, 2022-Solve M.E. submits new research paper citing about 7% of US adults suffering long COVID-19 symptoms, with personal financial burden estimated at USD386bn (C)2022 M2 COMMUNICATIONS Solve [...]

M2 PHARMA-March 3, 2022-Magellan Rx Management Releases Clinical Insights Paper on the Use of Psychedelics in Treating Mental Health Conditions (C)2022 M2 COMMUNICATIONS - US-based managed care company Magellan Health, [...]

M2 PHARMA-September 20, 2021-Ascend Performance Materials states SARS-CoV-2 virus is inactivated by zinc-embedded nylon fabric; Paper published in ACS Applied Materials Interfaces (C)2021 M2 COMMUNICATIONS Materials company Ascend Performance Materials [...]

M2 PHARMA-August 30, 2021-Recuro Health Publishes White Paper Documenting Value of an End-to-End Solution for At-Home COVID-19 Lab Testing to Ensure Workplace and School Safety (C)2021 M2 COMMUNICATIONS - US-based [...]

M2 PHARMA-October 26, 2020-Research paper reveals Australia's COVID-19 lockdown prevented about 400 deaths from other illnesses (C)2020 M2 COMMUNICATIONS A research paper published on 26 October 2020 has revealed that [...]

M2 PHARMA-August 27, 2020-Rapid Tests announces inexpensive, paper-strip technology to detect people infected with COVID-19 (C)2020 M2 COMMUNICATIONS Rapid Tests stated on Wednesday that its inexpensive, paper-strip technology Rapid can [...]

M2 PHARMA-May 29, 2020-Cellulotech's chromatogeny-treated paper passes ASTM F1862 external validation to provide eco-friendly alternative for COVID-19 masks (C)2020 M2 COMMUNICATIONS Cellulose R&D company Cellulotech said on Thursday that paper [...]

M2 PHARMA-March 19, 2020-The Lancet Publishes Papers from Two Studies of Takeda's Dengue Vaccine Candidate (C)2020 M2 COMMUNICATIONS - Medical journal The Lancet has published two papers related to Japanese [...]

M2 PHARMA-November 27, 2020-Kenyans bound for Dubai, UAE arrested with fake COVID-19 papers (C)2020 M2 COMMUNICATIONS Airport officials in Kenya on 26 November 2020 arrested 21 travellers who were headed [...]

M2 PHARMA-September 22, 2020-Albert Einstein College of Medicine, Children's Hospital at Montefiore (CHAM) and Yale University publishes paper titled 'Immune Responses to SARS-CoV-2 Infection in Hospitalized Pediatric and Adult Patients' [...]

M2 PHARMA-June 10, 2020-Three Stages to COVID-19 Brain Damage Identified by Top Neurologists in Journal of Alzheimer Disease Paper Baseline MRIs Encouraged for COVID Patients (C)2020 M2 COMMUNICATIONS - The [...]

M2 PHARMA-March 24, 2020-Cardax Releases White Paper on the Potential Role of Astaxanthin in the Treatment of Coronavirus Disease (C)2020 M2 COMMUNICATIONS - US-based biopharmaceutical company Cardax, Inc. (OTCQB: CDXI) [...]

M2 PHARMA-July 11, 2019-Savonix Publishes Paper in Cognition, Brain, Behavior (C)2019 M2 COMMUNICATIONS - US-based Savonix, a specialist in digital tests for cognitive health, has published a research paper in [...]

- A paper by UK-based biotechnology company Bicycle Therapeutics has been published in the February 15th issue of Cancer Research, the company said.The publication demonstrates the potential of Bicycles as [...]

M2 PHARMA-March 29, 2017-New paper by Research and Markets to illuminate Emphysema drug pipeline, manufacturing information and a general overview of drug landscape (C)2017 M2 COMMUNICATIONS Research and Markets have [...]

Dexter Corp. shareholders approved the company's previously announced sale of Dexter Nonwoven Materials to Ahlstrom Paper Group Oy for $275 million in cash. Seventy percent of the shares outstanding voted [...]

M2 PHARMA-June 12, 2015-Atossa Genetics wins US Patent for breast cancer detection using absorbent paper (C)2015 M2 COMMUNICATIONS Breast health company Atossa Genetics (NASDAQ:ATOS) announced on Thursday that it has [...]

M2 PHARMA-January 22, 2015-Roka Bioscience develops white paper for detection of Salmonella in peanut products under reliable & strict testing method (C)2015 M2 COMMUNICATIONS Molecular diagnostics company Roka Bioscience (NasdaqGM:ROKA) [...]

M2 PHARMA-August 4, 2014-EMA issues draft concept paper on good genomics biomarker practices (C)2014 M2 COMMUNICATIONS 4 August 2014 - The European Medicines Agency (EMA) said Monday it had published [...]

M2 PHARMA-March 17, 2014-Journal publishes paper for Kymab's Kymouse therapeutic antibody discovery platform (C)2014 M2 COMMUNICATIONS 17 March 2014 - UK monoclonal antibody biopharmaceutical company Kymab Ltd said yesterday that [...]

M2 PHARMA-March 6, 2014-Review paper underscores immunohistochemistry impact on diagnostic prostate pathology (C)2014 M2 COMMUNICATIONS 6 March 2014 - Danish tissue-based cancer diagnostics firm Dako, part of US Agilent Technologies [...]

M2 PHARMA-July 30, 2013-Foundation Medicine files IPO registration papers with US SEC(C)2013 M2 COMMUNICATIONS 30 July 2013 - US cancer diagnostics company Foundation Medicine Inc said Monday it had filed [...]

M2 PHARMA-July 25, 2013-Canadian researchers to develop bioactive paper to measure bronchitis in patients with airway diseases(C)2013 M2 COMMUNICATIONS 25 July 2013 - Researchers from Canada's McMaster University have obtained [...]

M2 PHARMA-September 7, 2011-Servier fakes papers for Protelos drug(C)2011 M2 COMMUNICATIONS 7 September 2011 - French drug maker Les Laboratoires Servier has fabricated documents connected with osteoporosis treatment drug Protelos, [...]

NAMS, the North American Membrane Society, has issued a second call for papers to be presented at its yearly conference. Hosted by Kraft Foods and the University of Alabama, the [...]

The European Water Association (EWA) has issued a call for papers for its international symposium, New Water Policies - The Water Framework Directive. EWA is collaborating with the Spanish Water [...]

Membrane professionals interested in contributing to MSTN's industry insight column may submit articles to: Susan Hanft, editor, Membrane & Separation Technology News at shanft@cebridge.net. Submissions should run from 1,200 to [...]

Membrane professionals interested in contributing to MST's Industry Insight column may submit articles to: Susan Hanft, Editor, Membrane & Separation Technology News at shanft@cebridge.net. Submissions should run from 1,200 to [...]

Membrane professionals interested in contributing to MSTs Industry Insight column may submit articles to: Susan Hanft, Editor, Membrane & Separation Technology News at shanft@cebridge.net. Submissions should run from 1,200 to [...]

M2 PHARMA-December 15, 2020-Industrial Paperboard Manufacturer Dura-Fibre to Provide Specialty Packaging for COVID-19 Vaccine (C)2020 M2 COMMUNICATIONS - US-based paperboard manufacturer Dura-Fibre has been selected to provide specialty laminated paperboard [...]

M2 PHARMA-July 24, 2020-UPM's Q2 2020 results impacted by COVID-19 lockdowns (C)2020 M2 COMMUNICATIONS UPM-Kymmene Corporation (UPM)(HEL: UPM), a Finnish forest industry company, reported on Thursday profit of EUR103m, or [...]

M2 PHARMA-October 10, 2018-3M introduces new advanced surgical skin prep solution to fight against SSIs (C)2018 M2 COMMUNICATIONS 3M Co (NYSE:MMM), an American multinational conglomerate corporation operating in the fields [...]

M2 PHARMA-July 4, 2018-Sorrento acquires lymphatic delivery platform from Kimberly-Clark (C)2018 M2 COMMUNICATIONS Sorrento Therapeutics Inc (NASDAQ:SRNE) has acquired the Sofusa lymphatic delivery technology platform from Kimberly-Clark Corporation (NYSE:KMB) for [...]

M2 PHARMA-October 19, 2017-Haemonetics Adds Abernathy as Board Member (C)2017 M2 COMMUNICATIONS - Braintree, Massachusetts-based hematology products and solutions provider Haemonetics Corp. (NYSE: HAE) has elected Robert E. Abernathy, a [...]

M2 PHARMA-August 7, 2013-Adamis Pharmaceuticals to acquire 3Mâ[euro](tm)s Dry Powder Inhaler technology for undisclosed sum(C)2013 M2 COMMUNICATIONS Biopharmaceutical company Adamis Pharmaceuticals Corporation (OTCQB: ADMP) announced on Tuesday the signing of [...]

M2 PHARMA-August 7, 2013-3M's Salmonella detection assay gets AOAC official method of analysis validation(C)2013 M2 COMMUNICATIONS 7 August 2013 - 3M Food Safety, part of US diversified technology specialist 3M [...]

M2 PHARMA-August 7, 2013-Adamis Pharmaceuticals Corporation to purchase Dry Powder Inhaler technology for asthma and chronic obstructive pulmonary disease(C)2013 M2 COMMUNICATIONS Biopharmaceutical company Adamis Pharmaceuticals Corporation (OTCQB:ADMP) revealed on Tuesday [...]

M2 PHARMA-June 18, 2013-3M launches computer-assisted coding system for small rural, community hospitals(C)2013 M2 COMMUNICATIONS 18 June 2013 - 3M Health Information Systems, part of US diversified technology specialist 3M [...]

M2 PHARMA-June 5, 2013-Bruker licenses patents from 3M under exclusive agreement(C)2013 M2 COMMUNICATIONS Bruker Corporation (Nasdaq:BRKR), a provider of high-performance scientific instruments and solutions for molecular and materials research, announced [...]

M2 PHARMA-May 31, 2013-3M's E.coli O157 detection assay gets Afnor's NF validation mark(C)2013 M2 COMMUNICATIONS 31 May 2013 - 3M Food Safety, part of US diversified technology specialist 3M Company [...]

M2 PHARMA-December 29, 2010-Crothall, 3M enter into partnership for infection control using ATP monitors(C)2010 M2 COMMUNICATIONS 29 December 2010 - US-based provider of support services to healthcare clients Crothall Healthcare [...]

M2 PHARMA-December 24, 2010-Meda sues 3M over sale of European pharmaceutical division(C)2010 M2 COMMUNICATIONS 24 December 2010 - Swedish pharmaceutical company Meda AB (STO: MEDA-A) filed yesterday a complaint against [...]

M2 PHARMA-September 9, 2010-3M to acquire Arizant for USD810m(C)2010 M2 COMMUNICATIONS 9 September 2010 - US diversified technology firm 3M Co (NYSE: MMM) said on Thursday it has agreed to [...]

* Whatman Selects CEO. After a year-long search for leadership, Whatman plc (Maidstone, Kent, UK) has appointed William Emhiser as new Chief Executive Officer effective November 1st. Emhiser is currently [...]

Polypore Names Toth as President, CEO. Polypore International, Inc. (Charlotte, NC), a global manufacturer of polymer membranes for filtration processes, medical devices and batteries, has appointed Robert Toth, as President [...]

Whatman Appoints CEO. Whatman PLC (Maidstone, Kent, UK) has named Timothy Haines Chief Executive Officer, effective September 1, 2005. Haines joins Whatman from Astex Technology, a privately held UK-based drug [...]

Whatman Benefits from Restructuring. Whatman PLC (Maidstone, Kent, UK) has returned to profitability following exceptional charges incurred during 2003 restructuring. In the six months to June 30, Whatman reported pretax [...]

VW Selects IdaTech Reformer. IdaTech (Boise, ID) has been chosen by German automaker Volkswagen to design and manufacture a metal membrane-based integrated fuel processor for a diesel powered fuel cell [...]

Membrane manufacturer Whatman Inc. is entering a joint two-year Cooperative Research and Development Agreement (CRADA) project with the U.S. FDA to devise a method for detecting food-borne pathogens using size-exclusion [...]